Introduction

Immunotherapy has revolutionised cancer treatment in recent years. However, some tumour types still do not respond to it, and resistance remains a common challenge. Advances in cell-based therapies and a deeper understanding of tumour immunology have fuelled research in this field, leading to the development of numerous novel immune-based treatments.

In this exciting context, the EACR is pleased to launch its first virtual conference on Next Generation Immunotherapies. Attendees will explore cutting-edge developments in immunotherapy, ranging from basic research to clinical applications, with a particular focus on innovative therapeutic strategies. The program will include invited talks from leading scientists in areas such as novel NK, T and myeloid cell therapies, and new combinatorial immune checkpoint blockade strategies. It will also include presentations selected from submitted abstracts and offer plenty of time for scientific discussion.

Register now

Target audience:

Scientists in academia and industry (both senior and young investigators) who are interested in the most recent developments in cancer immunotherapy. The conference will provide a broad overview and detailed knowledge of novel targets and new therapeutic strategies on this field.

Topics to be covered:

• CAR-T and other personalized T cell therapies 
• mRNA therapies
• Myeloid and cytokine targeting

Scientific Programme Committee:

• Maria Caffarel, Biogipuzkoa Health Research Institute, Spain (Chair)
• Arianna Calcinotto, Institute of Oncology Research, Switzerland 
• Toni Celià-Terrassa, Hospital del Mar Medical Research Institute (IMIM), Spain 
• Federica Sallusto, ETH Zurich, Switzerland

Lay summary of the conference topic:

Immunotherapy has transformed cancer treatment, but some cancers still do not respond well. Thanks to progress in cell therapies and better knowledge of how the immune system interacts with tumours, new immune-based treatments are being developed. To highlight these advances, the EACR is hosting its first virtual conference on Next Generation Immunotherapies. The event will cover the latest research and clinical innovations, including new therapies using NK, T cells and other immune cells, as well as combinatorial treatments. The program features top scientists, abstract presentations, and time for discussion.

Follow us on Bluesky and LinkedIn for updates